Ibane Abasolo Olaortua I am a researcher, head of the Drug Delivery & Targeting (DDT) group and a member of the Clinical Biochemistry Service. Our research is aimed at improving the treatment of various diseases through the use of nanoparticles of natural or synthetic origin that selectively deliver treatments to the cells that need them. I am also a member of the Department of Biochemistry and Molecular Biology of the Autonomous University of Barcelona and I participate in the VHIR Master's Degree in Translational Biomedicine where I coordinate the internship module. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Biologist Bioquímica Cross-departmental services LinkedIn Twitter Orcid Email Ibane Abasolo Olaortua LinkedIn Twitter Orcid Email Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Biologist Bioquímica Cross-departmental services I am a researcher, head of the Drug Delivery & Targeting (DDT) group and a member of the Clinical Biochemistry Service. Our research is aimed at improving the treatment of various diseases through the use of nanoparticles of natural or synthetic origin that selectively deliver treatments to the cells that need them. I am also a member of the Department of Biochemistry and Molecular Biology of the Autonomous University of Barcelona and I participate in the VHIR Master's Degree in Translational Biomedicine where I coordinate the internship module.
I graduated in Biochemistry and Biology at the University of Navarra. During my doctorate in the laboratories of Dr. Alfonso Calvo (CIMA, Pamplona) and Prof. Zhou Wang (Northwestern University, Chicago, USA), I studied the role of a peptide hormone, adrenomedullin, in cancer. Later, I continued my postdoctoral training in the group of Prof. F.X. Real (IMIM, Barcelona), where I acquired extensive experience in experimental mouse models, from the generation of transgenic models to their molecular characterization, an experience that I completed with a specialization in molecular imaging techniques at the IAT-PRBB. Since 2007, I have been working at Vall d'Hebron, where I started as a post-doctoral researcher and head of the technology platform called Functional Validation & Preclinical Research (FVPR)-U20 ICTS. Since 2021 I am also the leader of the Drug Delivery & Targeting group at VHIR and at the CIBER for Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN). My research, and that of my group, seeks to improve the treatment of different diseases through the use of nanoparticles and hydrogels. These systems are specifically designed to protect the therapeutic agent and cause it to be released where and when it is needed. Noteworthy, we work at all steps of the preclinical development, from the design of the nanomaterial, to its synthesis, characterization and testing in experimental models of the disease. I am currently leading two European projects (SafeNMT and Mimic-key) and two Spanish projects (PI21/00930 and NanoDireCT), focused on the treatment of cancer (breast, pancreas and prostate) and lysosomal storage diseases (Fabry, Sanfilippo and pycnodysostosis).
Projects Advancing on drug delivery-combined targeted treatments against human breast cancer and Leukemia (Oncotarget/Nano) IP: Simon Schwartz Navarro Collaborators: Ibane Abasolo Olaortua Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 28300 Reference: EUI2008-0170 Duration: 01/03/2009 - 01/03/2011 Development of nanomedicines for enzymatic replacement therapy in Fabry disease IP: Simon Schwartz Navarro Collaborators: Ibane Abasolo Olaortua Funding agency: Fundació La Marató de TV3 Funding: 214925 Reference: MARATV3/2010/101230 Duration: 03/02/2011 - 31/12/2014 POLYSFERA: Nanocápsulas poliméricas para liberación controlada y dirigida de fármacos antitumorales IP: Ibane Abasolo Olaortua Collaborators: - Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 505955 Reference: IPT-090000-2010-0001 Duration: 22/06/2010 - 21/06/2013 Activación de vías dependientes del oncogen BRAF en la tumorogénesis y metástasis del cáncer colorectal en modelos in vivo IP: Simon Schwartz Navarro Collaborators: Ibane Abasolo Olaortua Funding agency: Instituto de Salud Carlos III Funding: 219252 Reference: PI080771 Duration: 01/01/2009 - 30/06/2012 Pagination First page « Previous page ‹ … Page 2 Page 3 Page 4 Current page 5 Page 6 Next page › Last page »
